We serve Chemical Name:Pseudotropine CAS:135-97-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Pseudotropine
CAS.NO:135-97-7
Synonyms:8-Methyl-8-azabicyclo[3.2.1]octan-3-ol;3-Pseudotropanol;8-Azabicyclo[3.2.1]octan-3-ol, 8-methyl-;Pseudotropine;EINECS 205-226-5;MFCD00078060;3-exo-8-Methyl-8-azabicyclo[3.2.1]octan-3-ol
Molecular Formula:C8H15NO
Molecular Weight:141.211
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:233.0±0.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.526
PSA:23.47000
Exact Mass:141.115356
LogP:-0.10
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 8-Methyl-8-azabicyclo[3.2.1]octan-3-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-exo-8-Methyl-8-azabicyclo[3.2.1]octan-3-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,8-Methyl-8-azabicyclo[3.2.1]octan-3-ol Use and application,3-Pseudotropanol technical grade,usp/ep/jp grade.
Related News: Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality. Pseudotropine manufacturer Any US citizen who has been in the Hubei province in the last 14 days will be subject to up to 14 days of mandatory quarantine upon return to the United States. Pseudotropine supplier China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. Pseudotropine vendor Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality. Pseudotropine factory Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK.
